CHEMOMAB THERAPEUTICS LTD.
Last · NasdaqCM$1.39+0.01 (+0.72%)stale · yahoo · 56h ago
Market cap$10.19M7.3M sh
P/E · TTM-1.3fwd -46.3 · eps -1.04 · loss
Beta0.74vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.051$3.50
Volume17.2Ksession
Loading chart…
Press & signals
- GlobeNewswire
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- GlobeNewswire
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis